Skip to main content
. 2016 Oct 3;95(12):1931–1942. doi: 10.1007/s00277-016-2810-z

Table 2.

Stratified analyses of ATRA on an intention-to-treat basis by genetic risk group according to ELN recommendations and mutational status of NPM1, FLT3-ITD, DNMT3A, IDH1/2, CEBPA and RUNX1 on overall survival

graphic file with name 277_2016_2810_Tab2_HTML.jpg

*Log-likelihood ratio test